Latest Period
Q2 2026
Security Snapshot
TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) Institutional Ownership
CUSIP: 88032L605
13F Institutional Holders and Ownership History from Q1 2024 to Q2 2026
Institutions Reporting
111
Shares (Excl. Options)
30,340,331
Price
$14.55
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- TENX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 30,340,331
- Total 13F value
- $441,433,123
- Portfolio coverage rank
- 0%
- Share change
- +10,461,462
- Value change
- +$147,225,837
- Number of holders
- 111
- Shares outstanding
- 37,442,071
- SEC-reported price per share
- $1.83
- Insider filing price
- $1.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- TENX - TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share is tracked under CUSIP 88032L605.
- 111 institutions reported positions in Q2 2026.
- 25 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 79 to 111 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $339,417,068 to $441,433,123.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 111 institutions filings for Q2 2026.
Security key
88032L605
Latest holder period
Q2 2026
13F holders
111
13D/G owners
25
CIK / CUSIP context first
Open Q2 2026 holders
TENX full holder history
TENAX THERAPEUTICS, INC. SEC filings
TENAX THERAPEUTICS, INC. company facts
TENAX THERAPEUTICS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 88032L605:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
25
Security
TENX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | $42,301,662 | 3,942,373 | FMR LLC | 30 Jun 2026 | |||
| Vivo Opportunity Fund Holdings, L.P. | 9% | $55,264,065 | 3,458,327 | Vivo Opportunity Fund Holdings, L.P. | 30 Jun 2026 | |||
| BIOTECHNOLOGY VALUE FUND L P | 10% | 0% | $49,703,601 | +$19,202,223 | 3,110,363 | +63% | BVF PARTNERS L P/IL | 30 Jun 2026 |
| RTW INVESTMENTS, LP | 9.9% | 0% | $45,809,131 | +$15,964,404 | 2,866,654 | +53% | RTW Investments, LP | 30 Jun 2026 |
| ING GROEP NV | 7% | $39,806,163 | 2,639,666 | ING Groep N.V. | 19 Aug 2026 | |||
| Vestal Point Capital, LP | 9.9% | $18,525,720 | 2,470,096 | Vestal Point Capital, LP | 30 Sep 2024 | |||
| MILLENNIUM MANAGEMENT LLC | 5.8% | +83% | $32,525,916 | +$19,312,368 | 2,156,891 | +146% | Millennium Management LLC | 13 Aug 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 5.3% | $30,061,920 | 1,993,496 | Sphera Funds Management Ltd. | 17 Aug 2026 | |||
| Adage Capital Management, L.P. | 6.8% | $30,353,930 | 1,899,495 | Adage Capital Management, L.P. | 30 Jun 2026 | |||
| BlackRock, Inc. | 6.4% | $24,856,274 | 1,708,335 | BlackRock, Inc. | 30 Jun 2026 | |||
| PERCEPTIVE ADVISORS LLC | 4.5% | -17% | $27,166,000 | +$4,030,444 | 1,700,000 | +17% | Perceptive Advisors LLC | 30 Jun 2026 |
| Giordano Christopher Thomas | 4.3% | -35% | $27,015,884 | +$6,993,503 | 1,690,606 | +35% | Christopher Thomas Giordano | 31 Jul 2026 |
| Venrock Healthcare Capital Partners III, L.P. | 4.7% | -52% | $25,166,774 | -$6,075,804 | 1,574,892 | -19% | Venrock Healthcare Capital Partners III, L.P. | 30 Jun 2026 |
| Ikarian Capital, LLC | 2.9% | -54% | $17,269,586 | -$1,029,112 | 1,080,700 | -5.6% | Ikarian Capital, LLC | 30 Jun 2026 |
| Stonepine Capital Management, LLC | 3.7% | $14,588,992 | 975,200 | Stonepine Capital Management, LLC | 31 Mar 2026 | |||
| Logos Global Management LP | 3% | -69% | $11,968,000 | +$2,767,600 | 800,000 | +30% | Logos Global Management LP | 31 Mar 2026 |
| JANUS HENDERSON GROUP PLC | 10% | +150% | $4,172,774 | +$3,057,778 | 623,733 | +274% | JANUS HENDERSON GROUP PLC | 28 Nov 2025 |
| MORGAN STANLEY | 3.5% | -61% | $6,812,761 | +$2,147 | 596,564 | +0.03% | Morgan Stanley | 31 Mar 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.2% | -80% | $8,781,370 | -$33,721,695 | 586,990 | -79% | T. Rowe Price Associates, Inc. | 31 May 2026 |
| Point72 Asset Management, L.P. | 3.1% | -53% | $7,988,116 | +$1,653,828 | 533,965 | +26% | Point72 Asset Management, L.P. | 31 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC | 2.1% | -69% | $7,986,979 | +$3,293,848 | 533,889 | +70% | Millennium Management LLC | 31 Mar 2026 |
| Invus Global Management, LLC | 2.5% | -77% | $6,390,029 | 427,141 | 0% | Raymond Debbane | 31 Mar 2026 | |
| Dellora Investments LP | 2.3% | -68% | $5,904,188 | -$95,834 | 394,665 | -1.6% | Dellora Investments LP | 31 Mar 2026 |
| Lind Global Fund II LP | 0.78% | -83% | $3,029,101 | -$3,590,400 | 202,480 | -54% | Lind Global Fund II LP | 31 Mar 2026 |
| S.H.N. Financial Investments Ltd. | 5% | $1,052,814 | 179,050 | S.H.N. Financial Investments Ltd. | 31 Dec 2024 |
As of 30 Jun 2026, 111 institutional investors reported holding 30,340,331 shares of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX). This represents 81% of the company’s total 37,442,071 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
61%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 3,942,373 | +1122% | 0% | $57,361,528 |
| Vivo Capital, LLC | 6.7% | 2,500,000 | +1100% | 3.3% | $36,375,000 |
| BlackRock, Inc. | 4.6% | 1,727,988 | +10078% | 0% | $25,142,226 |
| PERCEPTIVE ADVISORS LLC | 4.5% | 1,700,000 | +17% | 0.38% | $24,735,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1% | 1,147,121 | +335% | 0% | $16,690,611 |
| MILLENNIUM MANAGEMENT LLC | 2.3% | 876,230 | +64% | 0.01% | $12,749,146 |
| Ikarian Capital, LLC | 2.1% | 787,600 | -23% | 1.9% | $11,459,580 |
| Candriam S.C.A. | 2% | 749,588 | 0.05% | $10,896,012 | |
| CITADEL ADVISORS LLC | 1.9% | 728,561 | +378% | 0.01% | $10,600,562 |
| RTW INVESTMENTS, LP | 1.9% | 696,570 | +88% | 0.09% | $10,135,094 |
| Stonepine Capital Management, LLC | 1.8% | 660,000 | -32% | 7.3% | $9,603,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 639,537 | +825% | 0% | $9,308,074 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.6% | 607,660 | -79% | 0% | $8,842,000 |
| MARSHALL WACE, LLP | 1.6% | 585,578 | +66% | 0.01% | $8,520,160 |
| BRAIDWELL LP | 1.6% | 584,412 | 0.31% | $8,503,195 | |
| Point72 Asset Management, L.P. | 1.5% | 556,761 | +4.3% | 0.01% | $8,100,873 |
| Velan Capital Investment Management LP | 1.5% | 549,985 | -5.7% | 4.9% | $8,002,282 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.4% | 540,126 | 0% | 0.01% | $7,858,833 |
| Woodline Partners LP | 1.4% | 531,254 | +64% | 0.02% | $7,729,746 |
| STATE STREET CORP | 1.4% | 510,814 | +1662% | 0% | $7,432,344 |
| Sofinnova Investments, Inc. | 1.3% | 500,039 | +379% | 0.39% | $7,275,567 |
| Jupiter Topco LLC | 1.2% | 451,226 | 0% | 0% | $6,567,594 |
| MORGAN STANLEY | 1.2% | 432,220 | -28% | 0% | $6,288,801 |
| Qube Research & Technologies Ltd | 1.1% | 429,893 | +1420% | 0.01% | $6,254,943 |
| Siren, L.L.C. | 1.1% | 427,141 | 0% | 0.13% | $6,214,902 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q2 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 30,340,331 | $441,433,123 | +$147,225,837 | $14.55 | 111 |
| 2026 Q1 | 21,225,929 | $339,417,068 | +$227,394,441 | $15.99 | 79 |
| 2025 Q4 | 6,948,963 | $84,695,355 | +$29,084,194 | $12.19 | 48 |
| 2025 Q3 | 4,720,738 | $35,929,590 | +$18,970,280 | $7.61 | 34 |
| 2025 Q2 | 2,231,961 | $12,926,914 | +$1,314,380 | $5.76 | 25 |
| 2025 Q1 | 2,006,422 | $13,111,231 | +$4,224,591 | $6.55 | 23 |
| 2024 Q4 | 1,362,190 | $8,426,122 | +$1,144,778 | $6.19 | 21 |
| 2024 Q3 | 1,228,920 | $4,253,022 | +$4,189,827 | $3.46 | 19 |
| 2024 Q2 | 18,829 | $57,207 | +$35,228 | $3.02 | 10 |
| 2024 Q1 | 7,235 | $30,532 | +$30,532 | $4.24 | 9 |